Myofascial pain syndrome: a treatment review

Mehul J Desai, Vikramjeet Saini, Shawnjeet Saini, Mehul J Desai, Vikramjeet Saini, Shawnjeet Saini

Abstract

Myofascial pain syndrome (MPS) is defined as pain that originates from myofascial trigger points in skeletal muscle. It is prevalent in regional musculoskeletal pain syndromes, either alone or in combination with other pain generators. The appropriate evaluation and management of myofascial pain is an important part of musculoskeletal rehabilitation, and regional axial and limb pain syndromes. This article reviews the current hypotheses regarding the treatment modalities for myofascial trigger points and muscle pain. Through a critical evidence-based review of the pharmacologic and nonpharmacologic treatments, the authors aim to provide clinicians with a more comprehensive knowledge of the interventions for myofascial pain.

References

    1. Leite F, Atallah A, El Dib R, et al. Cyclobenzaprine for the treatment of myofascial pain in adults. Cochrane Database Syst Rev. 2009;3:CD006830.
    1. Simons D, Travell J, Simons L, editors. Travell and Simons’ myofascial pain and dysfunction: the trigger point manual. 2nd ed. Baltimore: Williams & Wilkins; 1999.
    1. Wheeler A, Aaron G. Muscle pain due to injury. Curr Pain Headache Rep. 2001;5:441–446. doi: 10.1007/s11916-001-0055-5.
    1. Fomby E, Mellion M. Identifying and treating myofascial pain syndrome. Phys Sport Med. 1997;25:67–75.
    1. Lacey P, Dodd G, Shannon D. A double blind, placebo controlled study of piroxicam in the management of acute musculoskeletal disorders. Eur J Rheumatol Inflamm. 1984;7:95–104.
    1. van Tulder M, Koes B, Bouter L. Conservative treatment of acute and chronic nonspecific low back pain: a systematic review of randomized controlled trials of the most common interventions. Spine (Phila Pa 1976) 1997;22:2128–2156. doi: 10.1097/00007632-199709150-00012.
    1. Amlie E, Weber H, Holme I. Treatment of acute low-back pain with piroxicam: results of a double-blind placebo-controlled trial. Spine (Phila Pa 1976) 1987;12:473–476. doi: 10.1097/00007632-198706000-00010.
    1. Hsieh L, Hong C, Chern S. Efficacy and side effects of diclofenac patch in treatment of patients with myofascial pain syndrome of the upper trapezius. J Pain Symptom Manag. 2010;39:116–125. doi: 10.1016/j.jpainsymman.2009.05.016.
    1. Pohjolainen T, Jekunen A, Autio L. Treatment of acute low back pain with the COX-2-selective anti-inflammatory drug nimesulide: results of a randomized, double-blind comparative trial versus ibuprofen. Spine (Phila Pa 1976) 2000;25:1579–1585. doi: 10.1097/00007632-200006150-00019.
    1. Bosch H, Sigmund R, Hettich M. Efficacy and tolerability of intramuscular and oral meloxicam in patients with acute lumbago: a comparison with intramuscular and oral piroxicam. Curr Med Res Opin. 1997;14:29–38. doi: 10.1185/03007999709113340.
    1. Borg-Stein J. Cervical myofascial pain and headache. Curr Pain Headache Rep. 2002;6:324–330. doi: 10.1007/s11916-002-0055-0.
    1. Russell I, Kamin M, Bennett R. Efficacy of tramadol in treatment of pain in fibromyalgia. J Clin Rheumatol. 2000;6:250–257. doi: 10.1097/00124743-200010000-00003.
    1. Borg-Stein J, Simons D. Focused review: Myofascial pain. Arch Phys Med Rehabil. 2002;83(Suppl 1):540–7.
    1. Gerwin R. A review of myofascial pain and fibromyalgia—factors that promote their persistence. Acupunct Med. 2005;23:124–134. doi: 10.1136/aim.23.3.121.
    1. Lewis K, Han N. Tramadol: a new centrally acting analgesic. Am J Health Syst Pharm. 1997;54:643–652.
    1. Muller W, Stratz T. Local treatment of tendinopathies and myofascial pain syndromes with the 5-HT3 receptor antagonist tropisetron. Scand J Rheumatol Suppl. 2004;119:44–48. doi: 10.1080/03009740410007032.
    1. Fleckenstein J, Zaps D, Rüger L. Discrepancy between prevalence and perceived effectiveness of treatment methods in myofascial pain syndrome: results of a cross-sectional, nationwide survey. BMC Musculoskelet Disord. 2010;11:32. doi: 10.1186/1471-2474-11-32.
    1. Webster B, Verma S, Gatchel R. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use. Spine (Phila Pa 1976) 2007;32:2127–2132. doi: 10.1097/BRS.0b013e318145a731.
    1. Carterall W. Molecular mechanisms of gating and drug block of sodium channels. Sodium channels and neuronal hyperexcitability. Novartis Foundation Symposium 241; 2002.
    1. Affaitati G, Fabrizio A, Savini A, et al. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds. Clin Ther. 2009;31:705–720. doi: 10.1016/j.clinthera.2009.04.006.
    1. Dalpiaz A, Lordon S, Lipman A. Topical lidocaine patch therapy for myofascial pain. J Pain Palliat Care Pharmacother. 18:15–34.
    1. Dalpiaz A, Dodds T. Myofascial pain response to topical lidocaine patch therapy: case report. J Pain Palliat Care Pharmacother. 2002;16:99–104. doi: 10.1080/J354v16n01_08.
    1. Malanga G, Gwynn M, Smith R, Miller D. Tizanidine is effective in the treatment of myofascial pain syndrome. Pain Physician. 2002;5:422–432.
    1. Fishbain D, Cutler R, Rosomoff H, Rosomoff R. Clonazepam open clinical treatment trial for myofascial syndrome associated chronic pain. Pain Med. 2000;1:332–339. doi: 10.1046/j.1526-4637.2000.00044.x.
    1. Turturro M, Frater C, D’Amico F. Cyclobenzaprine with ibuprofen versus ibuprofen alone in acute myofascial strain: a randomized, double-blind clinical trial. Ann Emerg Med. 2003;41:818–826. doi: 10.1067/mem.2003.188.
    1. Carta M, Murru L, Botta P, et al. The muscle relaxant thiocolchicoside is an antagonist of GABAa receptor function in the central nervous system. Neuropharmacology. 2006;51:805–815. doi: 10.1016/j.neuropharm.2006.05.023.
    1. Biziere K, Huguet F, Narcisse G, Breteau M. Affinity of thiocolchicoside and thiocolchicoside analogues for the postsynaptic GABA receptor site. Eur J Pharmacol. 1981;75:167–168. doi: 10.1016/0014-2999(81)90080-7.
    1. Ketenci A, Basat H, Esmaeilzadeh S. The efficacy of topical thiocolchicoside (Muscoril) in the treatment of acute cervical myofascial pain syndrome: a single-blind, randomized, prospective, phase IV clinical study. Agri. 2009;21:95–103.
    1. Ketenci A, Ozcan E, Karamursel S. Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain. Int J Clin Pract. 2005;59:764–770. doi: 10.1111/j.1742-1241.2004.00454.x.
    1. Crofford L, Rowbotham M, Mease P, et al. Pregabalin for the treatment of fibromyalgia syndrome. Arthritis Rheum. 2005;52:1264–1273. doi: 10.1002/art.20983.
    1. Wheeler A. Myofascial pain disorders: theory to therapy. Drugs. 2004;64:45–62. doi: 10.2165/00003495-200464010-00004.
    1. Wiffen P, Collins S, McQuay H, Carrol D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev. 2005;20(3):CD001133.
    1. Micó J, Ardid D, Berrocoso E, Eschalier A. Antidepressants and pain. Trends Pharmacol Sci. 2006;27:348–354. doi: 10.1016/j.tips.2006.05.004.
    1. McQuay H, Tramèr M, Nye B, Carrol D, Wiffen P, Moore R. A systematic review of antidepressants in neuropathic pain. Pain. 1996;68:217–227. doi: 10.1016/S0304-3959(96)03140-5.
    1. Botney M, Fields H. Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol. 1983;13:160–164. doi: 10.1002/ana.410130209.
    1. Bendtsen L, Jensen R. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia. 2001;20:603–610. doi: 10.1046/j.1468-2982.2000.00087.x.
    1. Plesh O, Curtis D, Levine J, McCall W., Jr Amitriptyline treatment of chronic pain in patients with temporomandibular disorders. J Oral Rehabil. 2000;10:834–841. doi: 10.1046/j.1365-2842.2000.00572.x.
    1. Smith H, Smith E, Smith B. Duloxetine in the management of chronic musculoskeletal pain. Ther Clin Risk Manag. 2012;8:267–277. doi: 10.2147/TCRM.S17428.
    1. Borg-Stein J. Treatment of fibromyalgia, myofascial pain, and related disorders. Phys Med Rehabil Clin N Am. 2006;17:491–510. doi: 10.1016/j.pmr.2005.12.003.
    1. Dao T, Lund P, Remillard G, Lavigne G. Is myofascial pain of the temporal muscles relieved by oral sumatriptan? A cross-over pilot study. Pain. 1995;62:241–244. doi: 10.1016/0304-3959(95)00025-N.
    1. Fallah H, Currimbhoy S. Use of botulinum toxin A for treatment of myofascial pain and dysfunction. J Oral Maxillofac Surg. 2012;70:1243–1245. doi: 10.1016/j.joms.2012.01.015.
    1. Benecke R, Heinze A, Reichel G, Hefter H, Gobel H, Dysport Myofascial Pain Study Group Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections? Pain Med. 2011;12:1607–1614. doi: 10.1111/j.1526-4637.2011.01163.x.
    1. Göbel H, Heinze A, Reichel G, Hefter H, Gobel H, Dysport Myofascial Pain Study Group Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. Pain. 2006;125:82–88. doi: 10.1016/j.pain.2006.05.001.
    1. Soares A, Andriolo R, Atallah A, da Silva E. Botulinum toxin for myofascial pain syndromes in adults. Cochrane Database Syst Rev. 2012;18:CD007533.
    1. Ho K, Tan K. Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review. Eur J Pain. 2007;11:519–527. doi: 10.1016/j.ejpain.2006.09.002.
    1. Freund B, Schwartz M. Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study. J Rheumatol. 2000;27:481–484.
    1. Lew H, Lee E, Castaneda A, Klima A, Date E. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study. Arch Phys Med Rehabil. 2008;89:75–80. doi: 10.1016/j.apmr.2007.08.133.
    1. Wheeler A, Goolkasian P, Gretz S. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine (Phila Pa 1976) 1998;23:1662–1666. doi: 10.1097/00007632-199808010-00009.
    1. Graboski C, Gray D, Burnham R. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study. Pain. 2005;118:170–175. doi: 10.1016/j.pain.2005.08.012.
    1. Kamanli A, Kaya A, Ardicoglu O, Ozgocmen S, Zengin F, Bayik Y. Comparison of lidocaine injection, botulinum toxin injection, and dry needling. Rheumatol Int. 2005;25:604–611. doi: 10.1007/s00296-004-0485-6.
    1. Sławek J, Madaliński M, Maciag-Tymecka I, Duzynski W. Frequency of side effects after botulinum toxin A injections in neurology, rehabilitation and gastroenterology. Pol Merkur Lekarski. 2005;18:298–302.
    1. Castrillon E, Cairns B, Ernberg M, et al. Effect of peripheral NMDA receptor blockade with ketamine on chronic myofascial pain in temporomandibular disorder patients: a randomized, double-blinded, placebo-controlled trial. J Orofac Pain. 2008;22:122–130.
    1. Stockstill J, McCall W, Gross A, Piniewski B. The effect of l-tryptophan supplementation and dietary instruction on chronic myofascial pain. J Am Dent Assoc. 1989;118:457–460.
    1. Hong C. Lidocaine injection versus dry needling to myofascial trigger point. The importance of the local twitch response. Am J Phys Med Rehabil. 1994;73:256–263. doi: 10.1097/00002060-199407000-00006.
    1. Mayoral del Moral O. Dry needling treatments for myofascial trigger points. J Musculoskelet Pain. 2010;18:411–416. doi: 10.3109/10582452.2010.502632.
    1. Edwards J, Knowles N. Superficial dry needling and active stretching in the treatment of myofascial pain: a randomised control trial. Acupunct Med. 2003;21:80–86. doi: 10.1136/aim.21.3.80.
    1. Cummings T, White A. Needling therapies in the management of myofascial trigger point pain: a systemic review. Arch Phys Med Rehabil. 2001;82:986–992. doi: 10.1053/apmr.2001.24023.
    1. Kostopoulos D, Rizopoulos K. The manual of trigger point and myofascial therapy. New Jersey: SLACK Incorporated; 2001.
    1. Hou C, Tsai L, Cheng K, Chung K, Hong C. Immediate effects of various physical therapeutic modalities on cervical myofascial pain and trigger-point sensitivity. Arch Phys Med Rehabil. 2002;83:1406–1414. doi: 10.1053/apmr.2002.34834.
    1. Hong C, Chen Y, Pon C. Immediate effects of various physical medicine modalities on pain threshold of an active myofascial trigger point. J Musculoskelet Pain. 1993;1:37–53. doi: 10.1300/J094v01n02_04.
    1. Gam A, Warming S, Larsen L, et al. Treatment of myofascial trigger-points with ultrasound combined with massage and exercise—a randomised controlled trial. Pain. 1998;77:73–79. doi: 10.1016/S0304-3959(98)00084-0.
    1. Gam A, Johannsen F. Ultrasound therapy in musculoskeletal disorders: a meta-analysis. Pain. 1995;63:85–91. doi: 10.1016/0304-3959(95)00018-N.
    1. Aguilera FJ, Martín D, Masanet R, Botella A, Soler L, Morell F. Immediate effect of ultrasound and ischemic compression techniques for the treatment of trapezius latent myofascial trigger points in healthy subjects: a randomised controlled study. J Manipulative Physiol Ther. 2009;32:515–520. doi: 10.1016/j.jmpt.2009.08.001.
    1. Srbely J, Dickey J, Lowerison M, Edwards A, Nolet P, Wong L. Stimulation of myofascial trigger points with ultrasound induces segmental antinociceptive effects: a randomized controlled study. Pain. 2009;139:260–266. doi: 10.1016/j.pain.2008.04.009.
    1. Ay S, Doğan SK, Evcik D, Baser O. Comparison the efficacy of phonophoresis and ultrasound therapy in myofascial pain syndrome. Rheumatol Int. 2011;31:1203–1208. doi: 10.1007/s00296-010-1419-0.
    1. Sarrafzadeh J, Ahmadi A, Yassin M. The effects of pressure release, phonophoresis of hydrocortisone, and ultrasound on upper trapezius latent myofascial trigger point. Arch Phys Med Rehabil. 2012;93:72–77. doi: 10.1016/j.apmr.2011.08.001.
    1. Majlesi J, Unalan H. High-power pain threshold ultrasound technique in the treatment of active myofascial trigger points: a randomized, double-blind, case-control study. Arch Phys Med Rehabil. 2004;85:833–836. doi: 10.1016/j.apmr.2003.07.023.
    1. Crockett D, Foreman M, Alden L, Blasberg B. Comparison of treatment modes in the management of myofascial pain dysfunction syndrome. Biofeedback Self Regul. 1986;11:279–291. doi: 10.1007/BF01000164.
    1. Graff-Radford S, Reeves J, Baker R. Effects of transcutaneous electrical nerve stimulation on myofascial pain and trigger point sensitivity. Pain. 1989;37:1–5. doi: 10.1016/0304-3959(89)90146-2.
    1. Hsueh C, Cheng P, Kuan T, Hong C. The immediate effectiveness of electrical nerve stimulation and electrical muscle stimulation on myofascial trigger points. Am J Phys Med Rehabil. 1997;76:471–476. doi: 10.1097/00002060-199711000-00007.
    1. Lee J, Lin D, Hong C. The effectiveness of simultaneous thermotherapy with ultrasound and electrotherapy with combined AC and DC current on the immediate pain relief of myofascial trigger points. J Musculoskelet Pain. 1997;5:81–90. doi: 10.1300/J094v05n01_06.
    1. Farina S, Casarotto M, Benelle M, et al. A randomized controlled study on the effect of two different treatments (FREMS and TENS) in myofascial pain syndrome. Eura Medicophys. 2004;40:293–301.
    1. Gül K, Onal SA. Comparison of non-invasive and invasive techniques in the treatment of patients with myofascial pain syndrome. Agri. 2009;21:104–121.
    1. Chu J, Yuen K, Wang B, Chan R, Schwartz I, Neuhauser D. Electrical twitch-obtaining intramuscular stimulation in lower back pain: a pilot study. Am J Phys Med Rehabil. 2004;83:104–111. doi: 10.1097/01.PHM.0000107485.86594.8B.
    1. Chu J, Schwartz I. eToims twitch relief method in chronic refractory myofascial pain (CRMP) Electromyogr Clin Neurophysiol. 2008;48:311–320.
    1. Pujol J, Pascual-Leone A, Dolz C, Delgado E, Dolz J, Aldoma J. The effect of repetitive magnetic stimulation on localized musculoskeletal pain. Neuroreport. 1998;9:1745–1748. doi: 10.1097/00001756-199806010-00014.
    1. Smania N, Corato E, Fiaschi A, Pietropoli P, Aglioti S, Tinazzi M. Therapeutic effects of peripheral repetitive magnetic stimulation on myofascial pain syndrome. Clin Neurophysiol. 2003;114:350–358. doi: 10.1016/S1388-2457(02)00367-X.
    1. Smania N, Corato E, Fiaschi A, Pietropoli P, Aglioti S, Tinazzi M. Repetitive magnetic stimulation a novel therapeutic approach for myofascial pain syndrome. J Neurol. 2005;252:307–314. doi: 10.1007/s00415-005-0642-1.
    1. Ceylan Y, Hizmetli S, Siliğ Y. The effects of infrared laser and medical treatments on pain and serotonin degradation products in patients with myofascial pain syndrome. A controlled trial. Rheumatol Int. 2004;24:260–263. doi: 10.1007/s00296-003-0348-6.
    1. Gur A, Sarac A, Cevik R, Altindag O, Sarac S. Efficacy of 904 nm gallium arsenide low level laser therapy in the management of chronic myofascial pain in the neck: a double-blind and randomize-controlled trial. Lasers Surg Med. 2004;35:229–235. doi: 10.1002/lsm.20082.
    1. Ceccherelli F, Altafini L, Lo Castro G, Avila A, Ambrosio F, Giron G. Diode laser in cervical myofascial pain: a double-blind study versus placebo. Clin J Pain. 1989;5:301–304. doi: 10.1097/00002508-198912000-00005.
    1. Hakgüder A, Birtane M, Gürcan S, Kokino S, Turan F. Efficacy of low level laser therapy in myofascial pain syndrome: an algometric and thermographic evaluation. Lasers Surg Med. 2003;33:339–343. doi: 10.1002/lsm.10241.
    1. Ilbuldu E, Cakmak A, Disci R, Aydin R. Comparison of laser, dry needling, and placebo laser treatments in myofascial pain syndrome. Photomed Laser Surg. 2004;22:306–311. doi: 10.1089/pho.2004.22.306.
    1. Dundar U, Evcik D, Samli F, Pusak H, Kavunca V. The effect of gallium arsenide aluminum laser therapy in the management of cervical myofascial pain syndrome: a double blind, placebo-controlled study. Clin Rheumatol. 2007;26:930–934. doi: 10.1007/s10067-006-0438-4.
    1. Waylonis G, Wilke S, O’Toole D, Waylonis DA, Waylonis DB. Chronic myofascial pain: management by low-output helium-neon laser therapy. Arch Phys Med Rehabil. 1988;69:1017–1020.
    1. Altan L, Bingöl U, Aykaç M, Yurtkuran M. Investigation of the effect of GaAs laser therapy on cervical myofascial pain syndrome. Rheumatol Int. 2005;25:23–27. doi: 10.1007/s00296-003-0396-y.
    1. Thorsen H, Gam A, Svensson B, et al. Low level laser therapy for myofascial pain in the neck and shoulder girdle. A double-blind, cross-over study. Scand J Rheumatol. 1992;21:139–141. doi: 10.3109/03009749209095086.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する